June 12, 2026 · Form 4 insider transaction
Dambkowski Carl sold 12,583 shares of Oruka Therapeutics, Inc. at $70.11 per share, a transaction worth $882.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 19, 2026.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.50, inclusive.